机构风向标 | 新光药业(300519)2025年二季度已披露持仓机构仅4家

Core Insights - Xinguang Pharmaceutical (300519.SZ) released its semi-annual report for 2025, indicating a total of 29.12 million shares held by institutional investors, representing 18.20% of the company's total equity [1] Institutional Holdings - As of August 25, 2025, four institutional investors disclosed their holdings in Xinguang Pharmaceutical, with a combined ownership of 29.12 million shares, an increase of 0.75 percentage points from the previous quarter [1] - The institutional investors include Shengzhou Huanfeng Investment Co., Ltd., China Minsheng Bank Co., Ltd. - Jinyuan Shun'an Flexible Allocation Mixed Securities Investment Fund, BARCLAYS BANK PLC, and China Construction Bank Co., Ltd. - Nuoan Multi-Strategy Equity Fund [1] Public Fund Activity - One public fund, Jinyuan Shun'an Flexible Allocation Mixed Fund, increased its holdings compared to the previous period, while a new public fund, Nuoan Multi-Strategy Mixed A, was disclosed this quarter [1] - One public fund, Huatai-PineBridge CSI Traditional Chinese Medicine ETF, was not disclosed in this quarter compared to the previous one [1] Foreign Investment - One new foreign institutional investor, BARCLAYS BANK PLC, disclosed its holdings in Xinguang Pharmaceutical this quarter [1]